Sign In
Buy LGND
$287.54
-8.75 (-2.95%)
At Close: Jul 31, 2026
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global CD40 Ligand Market by Type (Monoclonal Antibody, Polyclonal Antibody), Application (Autoimmune Disease Treatment, Immunotherapy, Vaccine Developme
Ligand Pharmaceuticals Incorporated (LGND) Q2 2024 Earnings Call Transcript
10:58pm, Tuesday, 06'th Aug 2024
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Todd Davis - CEO Tavo Espinoza - CFO Paul Hadden - Senior Vice Presid
Ligand Pharmaceuticals: Solid Performer Performing Solidly
02:43pm, Monday, 29'th Jul 2024
Ligand Pharmaceuticals has seen over a 50% increase in share value since its Q1 earnings report. Recent positive developments include new deals, regulatory successes, and raising 2024 guidance. A new
Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
04:01pm, Tuesday, 23'rd Jul 2024
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2024 financial results after the close of the U.S. financial marke
5 Best Short-Term Stocks to Consider Investing In
09:01am, Wednesday, 10'th Jul 2024
Not every investor is in the market for the long haul. Some prefer short time frames and volatile stocks, looking to make a profit in days or weeks rather than years.
Ligand to Acquire APEIRON Biologics AG for $100 Million
07:00am, Monday, 08'th Jul 2024
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it has entered into a definitive agreement to acquire APEIRON Biologics AG, which holds royalty
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Verona Pharma plc has received approval from the U.S. Food and Drug Administration (
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
08:00am, Tuesday, 18'th Jun 2024
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its collaborator Merck, known as MSD outside the United States and Canada, has received approval
What Makes Ligand (LGND) a New Strong Buy Stock
01:01pm, Friday, 14'th Jun 2024
Ligand (LGND) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Why Is Ligand (LGND) Up 4% Since Last Earnings Report?
12:35pm, Thursday, 06'th Jun 2024
Ligand (LGND) reported earnings 30 days ago. What's next for the stock?
New Strong Buy Stocks for June 6th
07:56am, Thursday, 06'th Jun 2024
HWM, LGND, MATX, SMFKY and HAE have been added to the Zacks Rank #1 (Strong Buy) List on June 6, 2024.
Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect?
10:56am, Tuesday, 04'th Jun 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 32.3% in Ligand (LGND). While the effectiveness of this highly sought-after metric is questionable, the positiv
Recent Price Trend in Ligand (LGND) is Your Friend, Here's Why
09:52am, Tuesday, 04'th Jun 2024
Ligand (LGND) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our sho
Ligand to Participate in Upcoming Investor Conferences
04:59pm, Thursday, 23'rd May 2024
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Todd Davis (Chief Executive Officer) and Tavo Espinoza (Chief Financial Officer) will participat
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
06:00am, Monday, 20'th May 2024
Amid the rise of the digital innovation space, investors may want to consider biotech stocks to buy. Fundamentally, a rotation into the sector may occur, boding well for the ecosystem before the summe
